Brentuximab-Induced Acute Interstitial Nephritis: A Case Report
Brentuximab vedotin is a combination monoclonal antibody to anti-CD30 conjugated to the anti-tubulin agent monomethyl auristatin E. It is approved for the treatment of mycosis fungoides, Hodgkin’s lymphoma, and systemic anaplastic large cell lymphoma. Brentuximab has been associated with a number of...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2024-11-01
|
| Serie: | Canadian Journal of Kidney Health and Disease |
| Accesso online: | https://doi.org/10.1177/20543581241300766 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|